Brain phenotypes in two FGFR2 mouse models for Apert syndrome
Copyright (c) 2010 Wiley-Liss, Inc..
Apert syndrome (AS) is one of at least nine disorders considered members of the fibroblast growth factor receptor (FGFR) -1, -2, and -3-related craniosynostosis syndromes. Nearly 100% of individuals diagnosed with AS carry one of two neighboring mutations on Fgfr2. The cranial phenotype associated with these two mutations includes coronal suture synostosis, either unilateral (unicoronal synostosis) or bilateral (bicoronal synostosis). Brain dysmorphology associated with AS is thought to be secondary to cranial vault or base alterations, but the variation in brain phenotypes within Apert syndrome is unexplained. Here, we present novel three-dimensional data on brain phenotypes of inbred mice at postnatal day 0 each carrying one of the two Fgfr2 mutations associated with AS. Our data suggest that the brain is primarily affected, rather than secondarily responding to skull dysmorphogenesis. Our hypothesis is that the skull and brain are both primarily affected in craniosynostosis and that shared phenogenetic developmental processes affect both tissues in craniosynostosis of Apert syndrome.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2010 |
---|---|
Erschienen: |
2010 |
Enthalten in: |
Zur Gesamtaufnahme - volume:239 |
---|---|
Enthalten in: |
Developmental dynamics : an official publication of the American Association of Anatomists - 239(2010), 3 vom: 10. März, Seite 987-97 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Aldridge, Kristina [VerfasserIn] |
---|
Links: |
---|
Themen: |
EC 2.7.10.1 |
---|
Anmerkungen: |
Date Completed 06.12.2010 Date Revised 12.03.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.1002/dvdy.22218 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM194386198 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM194386198 | ||
003 | DE-627 | ||
005 | 20240312232724.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231223s2010 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/dvdy.22218 |2 doi | |
028 | 5 | 2 | |a pubmed24n1324.xml |
035 | |a (DE-627)NLM194386198 | ||
035 | |a (NLM)20077479 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Aldridge, Kristina |e verfasserin |4 aut | |
245 | 1 | 0 | |a Brain phenotypes in two FGFR2 mouse models for Apert syndrome |
264 | 1 | |c 2010 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 06.12.2010 | ||
500 | |a Date Revised 12.03.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright (c) 2010 Wiley-Liss, Inc. | ||
520 | |a Apert syndrome (AS) is one of at least nine disorders considered members of the fibroblast growth factor receptor (FGFR) -1, -2, and -3-related craniosynostosis syndromes. Nearly 100% of individuals diagnosed with AS carry one of two neighboring mutations on Fgfr2. The cranial phenotype associated with these two mutations includes coronal suture synostosis, either unilateral (unicoronal synostosis) or bilateral (bicoronal synostosis). Brain dysmorphology associated with AS is thought to be secondary to cranial vault or base alterations, but the variation in brain phenotypes within Apert syndrome is unexplained. Here, we present novel three-dimensional data on brain phenotypes of inbred mice at postnatal day 0 each carrying one of the two Fgfr2 mutations associated with AS. Our data suggest that the brain is primarily affected, rather than secondarily responding to skull dysmorphogenesis. Our hypothesis is that the skull and brain are both primarily affected in craniosynostosis and that shared phenogenetic developmental processes affect both tissues in craniosynostosis of Apert syndrome | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Fgfr2 protein, mouse |2 NLM | |
650 | 7 | |a EC 2.7.10.1 |2 NLM | |
650 | 7 | |a Receptor, Fibroblast Growth Factor, Type 2 |2 NLM | |
650 | 7 | |a EC 2.7.10.1 |2 NLM | |
700 | 1 | |a Hill, Cheryl A |e verfasserin |4 aut | |
700 | 1 | |a Austin, Jordan R |e verfasserin |4 aut | |
700 | 1 | |a Percival, Christopher |e verfasserin |4 aut | |
700 | 1 | |a Martinez-Abadias, Neus |e verfasserin |4 aut | |
700 | 1 | |a Neuberger, Thomas |e verfasserin |4 aut | |
700 | 1 | |a Wang, Yingli |e verfasserin |4 aut | |
700 | 1 | |a Jabs, Ethylin Wang |e verfasserin |4 aut | |
700 | 1 | |a Richtsmeier, Joan T |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Developmental dynamics : an official publication of the American Association of Anatomists |d 1994 |g 239(2010), 3 vom: 10. März, Seite 987-97 |w (DE-627)NLM012619930 |x 1097-0177 |7 nnns |
773 | 1 | 8 | |g volume:239 |g year:2010 |g number:3 |g day:10 |g month:03 |g pages:987-97 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/dvdy.22218 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 239 |j 2010 |e 3 |b 10 |c 03 |h 987-97 |